Health-tech startup Fitterfly launches X-Labs

To transform chronic disease management with AI Fitterfly, a health-tech company working in the field of digital therapeutics (DTx), has launched its new division, X-Labs on the occasion of its 7th Anniversary. The division harnesses the power of Artificial Intelligence (AI) and Human-centered Design to redefine the quality of care provided to individuals battling chronic conditions. With X labs, AI will start handling progress monitoring, set reminders, answer common queries, and provide routine information, while human coaches will deliver in-depth personalised care, surpassing the capabilities of when Fitterfly initially began its journey. The second mission is towards leveraging personalised data analysis and hybrid workflows to unleash the potential of data. Fitterfly will empower clients with insightful health journey understanding and actionable steps, nudging them towards their goals. We’re researching virtual biomarkers that quantify vital health information and complement glucose levels through biofeedback loops. With analysis overheads out of the way, Fitterfly's health professionals can focus on human-centric tasks, optimizing care and emphasising empathy. Dr Arbinder Singal, CEO and Co-Founder, Fitterfly said, "Through X-Labs, it is just the beginning of our journey to create a new era in healthcare, where cutting-edge technologies shape the future of patient care." Ammar J, Head, X-Labs, Fitterfly, said, "X-Labs embodies Fitterfly's commitment to innovation and bias for patient outcomes. With algorithmic insights and virtual biomarkers, rooted in evidence-based medicine, we’re reimagining the care continuum. By empowering our health professionals and our subscribing members, we plan to make a lasting impact on chronic disease management and rethink care pathways."